Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with unprecedented economic and societal impact. Currently, several vaccines are available and multitudes of antiviral treatments have been proposed and tested. Although many of the vaccines show clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonsdottir, Hulda R., Siegrist, Denise, Julien, Thomas, Padey, Blandine, Bouveret, Mendy, Terrier, Olivier, Pizzorno, Andres, Huang, Song, Samby, Kirandeep, Wells, Timothy N.C., Boda, Bernadett, Rosa-Calatrava, Manuel, Engler, Olivier B., Constant, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editions Scientifiques Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057985/
https://www.ncbi.nlm.nih.gov/pubmed/35658229
http://dx.doi.org/10.1016/j.biopha.2022.113058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057985/
https://www.ncbi.nlm.nih.gov/pubmed/35658229
http://dx.doi.org/10.1016/j.biopha.2022.113058

Ejemplares similares